Award
Delivery Order #75N95026F00001
Delivery Order for Process Development and Manufacture of AZM152 by Polypeptide Laboratories
Buyer
National Institutes of Health
Award Amount
$315,000.00
Ceiling
$826,000.00
Awarded
September 17, 2026
Period of Performance
Sep 17, 2026 – Sep 16, 2027
Identifier
75N95026F00001
NAICS
325411
This contract represents a delivery order awarded to Polypeptide Laboratories San Diego, LLC, a specialized pharmaceutical manufacturing company focused on advanced drug development services. The contract involves the process development and manufacture of AZM152, a drug substance, underscoring significant pharmaceutical manufacturing efforts tailored to healthcare innovation. The scope of work includes the development and production of this specific compound, supporting the broader mission of advancing drug manufacturing capabilities. This delivery order is connected as a task under a comprehensive Indefinite Delivery, Indefinite Quantity (IDIQ) contract dedicated to Chemistry, Manufacturing, and Controls (CMC) services for drug substances, reflecting a strategic continuation of longstanding collaboration with the Department of Health and Human Services. Awarded through a competitive process as an extension of the master IDIQ agreement, it demonstrates ongoing federal investment in small businesses contributing to public health priorities. The contract performance period spans one year with potential extension up to five years, reflecting a multi-year commitment to manufacturing excellence. The contract is performed in San Diego, California, reinforcing the region's role in pharmaceutical innovation and manufacturing.
Description
PROCESS DEVELOPMENT AND MANUFACTURE OF AZM152